Clinical Trial Update: InsuLearn Feasibility With Type 1 Diabetes Patients Under MDI Therapy [NA]

View source ↗

Summary

The clinical trial update notes the completion of a feasibility study evaluating InsuLearn in Type 1 Diabetes Mellitus patients under multiple daily injections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• InsuLearn

Snippet

Sponsor: University of Virginia | Conditions: Type 1 Diabetes Mellitus | NA | Status: COMPLETED